In search of preclinical robustness
Related Experiment Video
Updated: May 18, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Ian S Peers1, Peter R Ceuppens, Chris Harbron
1AstraZeneca 13F41 Mereside, Alderley Park, Macclesfield SK10 4TG, UK. Ian.Peers@astrazeneca.com
Abstract:
Systematic engagement of statisticians in preclinical research could help address the weaknesses that are undermining the likelihood of subsequent success in drug discovery and development.
Related Concept Videos
Preclinical Development: Overview
In vitro Mutagenesis
In-vitro Mutagenesis
Drug Discovery: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
In Vitro Drug Release Testing: Overview, Development and Validation
